These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 15088982

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Progesterone metabolites and bile acids in serum of patients with intrahepatic cholestasis of pregnancy: effect of ursodeoxycholic acid therapy.
    Meng LJ, Reyes H, Axelson M, Palma J, Hernandez I, Ribalta J, Sjövall J.
    Hepatology; 1997 Dec; 26(6):1573-9. PubMed ID: 9398000
    [Abstract] [Full Text] [Related]

  • 25. Metabolism and effects on cholestasis of isoursodeoxycholic and ursodeoxycholic acids in bile duct ligated rats.
    Purucker E, Marschall HU, Winograd R, Matern S.
    Biochim Biophys Acta; 2001 Apr 03; 1526(1):44-52. PubMed ID: 11287121
    [Abstract] [Full Text] [Related]

  • 26. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
    Ishizaki K, Iwaki T, Kinoshita S, Koyama M, Fukunari A, Tanaka H, Tsurufuji M, Sakata K, Maeda Y, Imada T, Chiba K.
    Eur J Pharmacol; 2008 Jan 06; 578(1):57-64. PubMed ID: 17888421
    [Abstract] [Full Text] [Related]

  • 27. [Effects of ursodeoxycholic acid on the biliary lipids secretion (author's transl)].
    Yanaura S, Izuka A, Ishikawa S.
    Nihon Yakurigaku Zasshi; 1981 Oct 06; 78(4):261-7. PubMed ID: 7327454
    [Abstract] [Full Text] [Related]

  • 28. Prevention of colitis-associated carcinogenesis in a mouse model by diet supplementation with ursodeoxycholic acid.
    Loddenkemper C, Keller S, Hanski ML, Cao M, Jahreis G, Stein H, Zeitz M, Hanski C.
    Int J Cancer; 2006 Jun 01; 118(11):2750-7. PubMed ID: 16385573
    [Abstract] [Full Text] [Related]

  • 29. A high-dose of ursodeoxycholic acid treatment alleviates liver inflammation by remodeling gut microbiota and bile acid profile in a mouse model of non-alcoholic steatohepatitis.
    Li H, Wang M, Chen P, Zhu M, Chen L.
    Biomed Pharmacother; 2024 May 01; 174():116617. PubMed ID: 38643542
    [Abstract] [Full Text] [Related]

  • 30. Effect of ursodeoxycholic acid administration after liver transplantation on serum liver tests and biliary complications: a randomized clinical trial.
    Wang SY, Tang HM, Chen GQ, Xu JM, Zhong L, Wang ZW, Deng GL, Xing TH, Lu LG, Peng ZH.
    Digestion; 2012 May 01; 86(3):208-17. PubMed ID: 22948036
    [Abstract] [Full Text] [Related]

  • 31. Effect of long term simvastatin administration as an adjunct to ursodeoxycholic acid: evidence for a synergistic effect on biliary bile acid composition but not on serum lipids in humans.
    Lanzarotto F, Panarotto B, Sorbara R, Panteghini M, Pagani F, Sosta S, Lanzini A.
    Gut; 1999 Apr 01; 44(4):552-6. PubMed ID: 10075964
    [Abstract] [Full Text] [Related]

  • 32. Mechanism of ursodeoxycholic acid- and canrenoate-induced biliary bicarbonate secretion and the effect on glucose- and amino acid-induced cholestasis.
    Omland E, Mathisen O.
    Scand J Gastroenterol; 1991 May 01; 26(5):513-22. PubMed ID: 1871544
    [Abstract] [Full Text] [Related]

  • 33. Ursodeoxycholic acid improves gastrointestinal motility defects in gallstone patients.
    Colecchia A, Mazzella G, Sandri L, Azzaroli F, Magliuolo M, Simoni P, Bacchi-Reggiani ML, Roda E, Festi D.
    World J Gastroenterol; 2006 Sep 07; 12(33):5336-43. PubMed ID: 16981264
    [Abstract] [Full Text] [Related]

  • 34. Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats.
    Nowak G, Norén UG, Wernerson A, Marschall HU, Möller L, Ericzon BG.
    Transpl Int; 2005 May 07; 17(12):804-9. PubMed ID: 15815896
    [Abstract] [Full Text] [Related]

  • 35. Effect of cholestyramine on bile acid pattern and synthesis during administration of ursodeoxycholic acid in man.
    Rust C, Sauter GH, Oswald M, Büttner J, Kullak-Ublick GA, Paumgartner G, Beuers U.
    Eur J Clin Invest; 2000 Feb 07; 30(2):135-9. PubMed ID: 10651838
    [Abstract] [Full Text] [Related]

  • 36. Effects of oral ursodeoxycholic acid in healthy cats on clinicopathological parameters, serum bile acids and light microscopic and ultrastructural features of the liver.
    Nicholson BT, Center SA, Randolph JF, Rowland PJ, Thompson MB, Yeager AE, Erb HN, Corbett J, Watrous D.
    Res Vet Sci; 1996 Nov 07; 61(3):258-62. PubMed ID: 8938858
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.